Complete Filing Data
Mingteng International Corp Inc. reported Stockholders Equity of $8.45 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Mingteng International Corp Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenues | $10.1M | $8.2M | $8.0M |
| Research And Development Expense | $634.0K | $630.8K | $492.5K |
| Other Nonoperating Income | $19.2K | $34.4K | $58.3K |
| Operating Income Loss | -$5.1M | $1.7M | $2.4M |
| Operating Expenses | $8.2M | $1.6M | $1.6M |
| Net Income Loss | -$5.7M | $1.5M | $2.1M |
| Income Tax Expense Benefit | $80.0K | $344.6K | $327.4K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$5.6M | $1.9M | $2.5M |
| Gross Profit | $3.1M | $3.3M | $3.9M |
| General And Administrative Expense | $7.4M | $797.1K | $926.8K |
| Cost Of Revenue | $7.1M | $4.9M | $4.1M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$5.7M | $1.4M | $1.7M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$37.2K | -$133.7K | -$479.8K |
| Interest Expense Nonoperating | $36.8K | $59.5K | $54.0K |
| Nonoperating Income Expense | -$486.5K | $108.6K | $99.3K |
| Deferred Income Tax Expense Benefit | -$21.9K | $254.2K | -$4.3K |
| Income Taxes Paid | $113.1K | $205.8K | $54.0K |
| Deferred Income Tax Liabilities Net | $221.6K | $246.9K | |
| Income Tax Expense Benefit Continuing Operations Government Grants | $129.1K | $92.8K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity | $8.5M | $7.4M | $6.1M | $4.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.1M | $1.1M | $1.8M | $307.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.0M | -$737.1K | $1.5M | |
| Short Term Bank Loans And Notes Payable | $1.4M | $282.4K | $1.4M | |
| Retained Earnings Accumulated Deficit | $787.2K | $6.5M | $5.0M | |
| Property Plant And Equipment Net | $3.9M | $3.3M | $2.6M | |
| Other Receivables Net Current | $15.7K | $12.3K | $5.3K | |
| Liabilities Noncurrent | $242.0K | $246.9K | $69.0K | |
| Liabilities Current | $5.3M | $3.0M | $3.9M | |
| Liabilities And Stockholders Equity | $14.0M | $10.7M | $10.1M | |
| Liabilities | $5.5M | $3.3M | $4.0M | |
| Inventory Net | $1.2M | $1.2M | $1.1M | |
| Common Stock Value | $68.00 | $50.00 | $50.00 | |
| Cash And Cash Equivalents At Carrying Value | $2.1M | $1.1M | $1.8M | |
| Assets Noncurrent | $5.3M | $4.1M | $3.8M | |
| Assets Current | $8.6M | $6.7M | $6.3M | |
| Assets | $14.0M | $10.7M | $10.1M | |
| Additional Paid In Capital Common Stock | $7.6M | $897.3K | $897.3K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$419.6K | -$382.4K | -$248.6K | |
| Accounts Receivable Net Current | $4.2M | $3.5M | $2.4M | |
| Accounts Payable Current | $1.3M | $1.1M | $718.3K | |
| Accounts And Other Receivables Net Current | $971.0K | $471.2K | $785.6K | |
| Finance Lease Principal Payments | $12.5K | $230.4K | ||
| Gain Loss On Sale Of Property Plant Equipment | -$24.9K | -$648.00 | ||
| Dividends Common Stock Cash | $352.1K | |||
| Deferred Costs | $715.8K | $550.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $945.9K | $761.8K | $1.4M |
| Net Cash Provided By Used In Operating Activities | $295.0K | $1.3M | $2.9M |
| Net Cash Provided By Used In Investing Activities | -$3.4M | -$761.8K | -$1.4M |
| Net Cash Provided By Used In Financing Activities | $4.2M | -$1.2M | $165.6K |
| Increase Decrease In Prepaid Supplies | -$196.1K | $152.0K | $223.6K |
| Increase Decrease In Other Receivables | -$28.6K | $35.7K | -$760.2K |
| Increase Decrease In Inventories | $39.8K | $180.3K | -$194.7K |
| Increase Decrease In Due To Related Parties | $3.4K | -$70.8K | -$348.3K |
| Increase Decrease In Accrued Income Taxes Payable | $662.9K | -$269.7K | $354.6K |
| Increase Decrease In Accounts Receivable | $705.9K | $1.1M | $489.1K |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | $134.4K | -$32.9K | $166.4K |
| Increase Decrease In Accounts Payable | $76.0K | $348.6K | $224.5K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.6K | -$26.3K | -$99.2K |
| Increase Decrease In Operating Lease Liability | -$5.8K | -$88.6K | -$85.1K |
| Depreciation Depletion And Amortization | $404.9K | $272.2K | |
| Proceeds From Short Term Debt | $1.4M | $1.4M | $1.7M |
| Increase Decrease In Accounts And Other Receivables | $511.6K | -$302.8K | $294.4K |
| Share Based Compensation | $4.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 5.9M | 5.0M | 5.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 5.9M | 5.0M | 5.0M |
| Earnings Per Share Diluted | $-0.97 | $0.30 | $0.43 |
| Earnings Per Share Basic | $-0.97 | $0.30 | $0.43 |
| Common Stock Shares Outstanding | 6.8M | 5.0M | 5.0M |
| Common Stock Shares Issued | 6.8M | 5.0M | 5.0M |
| Common Stock Shares Authorized | 5.00B | 5.00B | 5.00B |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Selling Expense | $150.4K | $153.2K | $132.5K |
| Interest Paid Net | $36.8K | $59.5K | $101.5K |
| Interest Income Other | $1.2K | $4.5K | $2.2K |
| Payment Of Financing And Stock Issuance Costs | $265.0K | $172.2K | $144.0K |
| Supplies | $122.5K | $388.1K | $240.6K |
| Statutory Accounting Practices Statutory Capital And Surplus Balance | $465.6K | $465.6K | $465.6K |
| Provision For Doubtful Accounts | -$5.1K | $17.6K |
Most recent annual filing with the SEC: April 30, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.